Skip to content

Safer labour induction with the EBLIA balloon

Novel extended balloon labour induction/augmentation (EBLIA) device to improve safety of labour induction: preliminary clinical study

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11399176
Enrollment
60
Registered
2026-05-15
Start date
2026-06-04
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnant participants due for labour induction Pregnancy and Childbirth

Interventions

Preliminary proof-of-concept clinical trial: The initial trial is designed to assess essential safety, performance, feasibility and acceptability and to give an indication of effectiveness and suitabi

Sponsors

Wits Health Consortium, University of the Witwatersrand
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Age >18 years 2. Planned labour induction 3. Singleton cephalic pregnancy 4. Gestation 36 weeks or more 5. Suitable for balloon labour induction 6. Informed consent

Exclusion criteria

Exclusion criteria: Major medical complications such as cardiac disease, diabetes, severe pre-eclampsia

Design outcomes

Primary

MeasureTime frame
Established labour (cervical dilation 5 cm or more) within 48 hours without use of amniotomy or uterine stimulants measured using clinical assessment of uterine contractions and cervical dilation in cm at during routine labour assessments

Secondary

MeasureTime frame
Mode of birth measured using clinical assessment at birth;Vaginal birth without use of uterine stimulants or amniotomy measured using clinical assessment at birth;Fetal heart rate parameters measured using cardiotocography at during labour;Uterine hyper-stimulation (5 or more contractions per 10 minutes) measured using cardiotocography at during labour;5-minute Apgar score <7 measured using clinical assessment at 5 minutes after birth;Maternal complications measured using clinical assessment at hospital discharge;Usability and acceptability to staff and participants measured using structured and semi-structured questionnaires at postpartum

Countries

South Africa

Contacts

Public ContactG Justus Hofmeyr
justhof@gmail.com+27 (0)832809402

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 23, 2026